Cited by 439Mitochondrial Function and PathologyPancreatic function and diabetesDiabetes and associated disorders

Mitochondrial Diabetes

Open access
Maassen, J. Antonie, ‘t Hart, Leen. M., van Essen, Einar, Heine, Rob J., Nijpels, Giel, Jahangir Tafrechi, Roshan S., Raap, Anton K., Janssen, George M.C. +1 more·2004·Diabetes

Abstract

Mutations in mitochondrial DNA (mtDNA) associate with various disease states. A few mtDNA mutations strongly associate with diabetes, with the most common mutation being the A3243G mutation in the mitochondrial DNA-encoded tRNA(Leu,UUR) gene. This article describes clinical characteristics of mitochondrial diabetes and its molecular diagnosis. Furthermore, it outlines recent developments in the pathophysiological and molecular mechanisms leading to a diabetic state. A gradual development of pancreatic beta-cell dysfunction upon aging, rather than insulin resistance, is the main mechanism in developing glucose intolerance. Carriers of the A3243G mutation show during a hyperglycemic clamp at 10 mmol/l glucose a marked reduction in first- and second-phase insulin secretion compared with noncarriers. The molecular mechanism by which the A3243G mutation affects insulin secretion may involve an attenuation of cytosolic ADP/ATP levels leading to a resetting of the glucose sensor in the pancreatic beta-cell, such as in maturity-onset diabetes of the young (MODY)-2 patients with mutations in glucokinase. Unlike in MODY2, which is a nonprogressive form of diabetes, mitochondrial diabetes does show a pronounced age-dependent deterioration of pancreatic function indicating involvement of additional processes. Furthermore, one would expect that all mtDNA mutations that affect ATP synthesis lead to diabetes. This is in contrast to clinical observations. The origin of the age-dependent deterioration of pancreatic function in carriers of the A3243G mutation and the contribution of ATP and other mitochondrion-derived factors such as reactive oxygen species to the development of diabetes is discussed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diabetes.53.2007.s103

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The most common mutation leading to mitochondrial diabetes is the A3243G mutation in the mitochondrial encoded tRNA (Leu, UUR) gene.

    “The most common mutation leading to mitochondrial diabetes is the A3243G mutation in the mitochondrial encoded tRNA (Leu, UUR) gene (205, 206).”
  • Mitochondrial diabetes is more likely to result from a gradual deterioration of β-cell function than from an acute functional impairment due to insufficient ATP production.

    “These data suggest that mitochondrial diabetes is more likely to result from a gradual deterioration of ␤-cell function, rather than from an acute functional impairment due to insufficient ATP production (246).”
  • Mitochondrial diabetes only develops upon aging, with an average age of onset between 35 and 40 years for MIDD and 48 years for the 14577 T>C mutation.

    “Interestingly, mitochondrial diabetes only develops upon aging, with an average age of onset between 35 and 40 yr for MIDD and 48 yr for 14577 TϾC.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Maassen, J. A., ‘t Hart, L. M., van Essen, E., Heine, R. J., Nijpels, G., Jahangir Tafrechi, R. S., Raap, A. K., Janssen, G. M. C., & Lemkes, H. H. P. J.
Affiliations
  • Leiden University Medical Center (NL)
  • Department of Molecular Cell Biology, Leiden University Medical Centre, Leiden, the Netherlands
  • Department of Endocrinology and Metabolic Diseases, Leiden University Medical Centre, Leiden, the Netherlands
  • Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Venue
Diabetes
Published
2004-02-01
Volume
53
Issue
suppl_1
Pages
S103-S109
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2101260083
Cited by
439
References
47
Citations by year
2026: 6 · 2025: 23 · 2024: 12 · 2023: 21 · 2022: 19 · 2021: 23 · 2020: 19 · 2019: 17 · 2018: 18 · 2017: 17 · 2016: 17 · 2015: 18 · 2014: 18 · 2013: 27 · 2012: 28
FWCI
1.95
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • European Commission
  • Diabetes Fonds
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
mitochondrial diabetes, mitochondrial DNA mutations, A3243G mutation, tRNA-Leu(UUR), beta-cell dysfunction, insulin secretion, impaired glucose tolerance, glucose sensor, maturity-onset diabetes of the young, glucokinase, reactive oxygen species, ATP production
MeSH terms
Insulin Secretion, Animals, Base Sequence, Diabetes Mellitus, Humans, Insulin, Mitochondria, Molecular Sequence Data, Nucleic Acid Conformation, RNA, Transfer, Leu, Incidence, Glucose Intolerance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review